LabPulse.com staff writersFinancingHarbinger Health raises $140M in series B fundingBiotech company Harbinger Health has raised $140 million in a series B funding round.September 29, 2023AgreementBioMérieux subsidiary secures DoD contract for infectious disease testing systemBioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.September 29, 2023KickbackU.S. Attorney’s Office wins $370M judgment in Medicare fraud caseThe U.S. Attorney's Office for the Middle District of Florida won a $370 million default judgment against a Kentucky lab owner and his businesses for a lab testing scheme intended to defraud Medicare.September 28, 2023CollaborationGinkgo Bioworks, Pfizer collaborate on RNA-based therapeuticsCell engineering company Ginkgo Bioworks has entered into an agreement with Pfizer to discover and develop RNA-based drug candidates.September 28, 2023COVID-19Study launched on early intervention with immune modulators in COVID-19A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.September 26, 2023COVID-19U.S. government investing $600M in COVID-19 test manufacturingThe U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.September 26, 2023StockInvitae receives noncompliance notice from NYSESan Francisco-based medical genetics company Invitae received a notice of noncompliance from the New York Stock Exchange (NYSE) on September 20 for its stock price closing under $1.00 per share for 30 consecutive days.September 25, 2023HIVHIV vaccine trial begins enrollment in U.S., South AfricaA clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.September 25, 2023Artificial IntelligenceAI model reveals kidney tumor features, potential for treatment response predictionResearchers at the Dana-Farber Cancer Institute have trained artificial intelligence (AI) models to assess the clinical features of kidney cancer tumor samples to predict how tumors may respond to immune therapy.September 22, 2023Regulatory GuidanceNIH to require international collaborators to share all dataDespite concerns from researchers and organizations, the U.S. National Institutes of Health (NIH) will implement its new mandate requiring foreign partners to share raw data and notebooks at regular set intervals with their primary U.S. grant recipients.September 22, 2023Page 1 of 321Next PageTop StoriesAgreementBioMérieux subsidiary secures DoD contract for infectious disease testing systemBioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.SchizophreniaGenetic predisposition to smoking may drive schizophrenia heart disease risk: StudyFinancingHarbinger Health raises $140M in series B fundingMalariaStudy shows malaria drug resistance occurring in Horn of AfricaSponsor ContentLatest in at-home or lab-based STI testing